In normal-aging mice, acarbose lined up with better spatial memory, and the same pattern did not hold in an Alzheimer model

What the research found

A mouse experiment was published on 12 November 2026. Shannon J. Moore, Geoffrey G. Murphy, and colleagues gave acarbose at 1000 ppm from 4 months of age and tested spatial learning and memory in a Morris water maze. Cohorts were 6 months, 12 months, and 24 months, in normal-aging mice and in an Alzheimer-model cross (5xFAD on the same mixed background). The abstract does not give a sample size, a sex split, or a p value, so those figures are not stated here, and the audience tags stay all and all ages. Acarbose is a diabetes medicine. This experiment is not a reason to take it, and it is not a substitute for a medicine a clinician has directed. In the normal-aging mice at 12 and 24 months, the abstract reports a moderate improvement in age-related spatial learning and a clearer improvement in spatial memory, with performance described as similar to the 6-month group, and a larger effect at older ages. The same treatment did not improve the worsening memory impairments in the Alzheimer-model mice. The introduction asks whether interventions that extend lifespan also support memory. Mouse data only. DOI 10.1007/s11357-026-02621-0. Not medical advice.

Evidence level: Animal study. Results in animals or cells often don't carry over to people.

Read the original at GeroScience